Early prediction of response to 40 kDa peginterferon alfa-2a (PEGASYS®) plus ribavirin (RBV) in patients with chronic hepatitis C (CHC) - Ferenci,P.; Shiffman,M.; Fried,M. (Hepatology, 2001)